Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Altanova is a specialty pharmaceutical company headquartered in South Plainfield, New Jersey, dedicated to the commercialization of branded prescription products. The company maintains a diverse portfolio of legacy and niche brands across therapeutic areas such as cardiovascular health, gastroenterology, and dermatology. In October 2021, Altanova was acquired by Exeltis, the U.S. specialty pharmaceutical division of Insud Pharma, to enhance its presence in the American market. Its product offerings include the K-Phos line of phosphate supplements and various topical treatments for skin conditions. The company focuses on providing reliable access to established therapies that address specific patient needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Altanova.